Skip to main content

Table 1 Demographic status of subjects in the intervention and control groups at baseline (N = 86)

From: Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial

Characteristics Intervention N = 44 Control N = 42 p.value*
Sex Male 27 (61.4%) 22 (52.4%) 0.400
Female 17 (38.6%) 20 (47.6%)
Underlying diseases Diabetes 15 (34.1%) 13 (31.0%) 0.756
Cardiovascular disease 12 (27.3%) 14 (33.3%) 0.541
Hypertension 19 (43.2%) 20 (47.6%) 0.679
Renal disease 2 (4.5%) 0 (0%) 0.495
Liver disease 0 (0%) 0 (0%)
Others 1 (2.3%) 3 (7.1%) 0.355
Smoking Non-smoker 27 (61.4%) 27 (64.3%) 0.699
Ex-smoker 9 (20.5%) 10 (23.8%)
Smoker 8 (18.2%) 5 (11.9%)
O2 saturation < 85 22 (52.4%) 20 (48.8%) 0.743
Age (year); mean ± standard deviation  56.2 ± 17.5 61.3 ± 17.3 0.174
  1. * Chi square, Fisher’s Exact Test, T test